Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7996)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2022 (publication date) through May 5, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ, Dang SS, Jia XL. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol 2022; 14(10): 1933-1948 [PMID: 36310697 DOI: 10.4251/wjgo.v14.i10.1933] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ, Dang SS, Jia XL. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol 2022; 14(10): 1933-1948 [PMID: 36310697 DOI: 10.4251/wjgo.v14.i10.1933] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i10/1933.htm |
| Number | Citing Articles |
| 1 |
Zhenbang Ye, Ning Huang, Yongliang Fu, Rongle Tian, Liming Wang, Wenting Huang. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients. eLife 2024; 13 doi: 10.7554/eLife.92841.3
|
| 2 |
Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin. Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05651-3
|
| 3 |
Hao Chi, Songyun Zhao, Jinyan Yang, Xinrui Gao, Gaoge Peng, Jinhao Zhang, Xixi Xie, Guobin Song, Ke Xu, Zhijia Xia, Shi Chen, Jinqiu Zhao. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1137025
|
| 4 |
Jingdi Zhang, Amna Rafique, Jie Liu, Muhammad Saqlain, Bo Yang, Ding Zhang, Ruiyan Niu, Zilong Sun. Deoxynivalenol-induced hepatic and renal injury via pyroptosis under heat stress conditions. Toxicology Letters 2026; 419: 111888 doi: 10.1016/j.toxlet.2026.111888
|
| 5 |
Yunhe Liu, Ansam Sinjab, Jimin Min, Guangchun Han, Francesca Paradiso, Yuanyuan Zhang, Ruiping Wang, Guangsheng Pei, Yibo Dai, Yang Liu, Kyung Serk Cho, Enyu Dai, Akshay Basi, Jared K. Burks, Kimal I. Rajapakshe, Yanshuo Chu, Jiahui Jiang, Daiwei Zhang, Xinmiao Yan, Paola A. Guerrero, Alejandra Serrano, Mingyao Li, Tae Hyun Hwang, Andrew Futreal, Jaffer A. Ajani, Luisa M. Solis Soto, Amir A. Jazaeri, Humam Kadara, Anirban Maitra, Linghua Wang. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell 2025; 43(5): 905 doi: 10.1016/j.ccell.2025.03.004
|
| 6 |
Shiqi Zhou, Chunwei Liu, Xiaodong Meng, Lingyu Kong, Wei Liu, Yuan Tian. Identification of Molecular Subtypes for Hepatocellular Carcinoma Based on Ubiquitin‐Conjugating Enzyme E2 (UBE2)‐Related Genes to Assess Prognosis and Immune Landscape. Immunity, Inflammation and Disease 2026; 14(3) doi: 10.1002/iid3.70409
|
| 7 |
Wei Yan, Lin Qiu, Meiling Yang, Anran Xu, Manqi Ma, Qinzi Yuan, Xiaochen Ma, Wenjuan Liang, Xuenong Li, Yanxia Lu. CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer. Cancer Letters 2023; 567: 216263 doi: 10.1016/j.canlet.2023.216263
|
| 8 |
Xinrong Lin, Chuan Tian, Fan Pan, Rui Wang. A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma. Oncologie 2024; 26(1): 91 doi: 10.1515/oncologie-2023-0360
|
| 9 |
Lifei Deng, Hong Ran, Dunhui Yang, Zhen Wang, Peng Zhao, Hengjie Huang, Yongjin Wu, Peng Zhang. TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-024-13417-w
|